2012
DOI: 10.3109/14653249.2011.610302
|View full text |Cite
|
Sign up to set email alerts
|

Increased apoptosis in cryopreserved autologous hematopoietic progenitor cells collected by apheresis and delayed neutrophil recovery after transplantation: a nested case-control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
15
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 24 publications
0
15
0
1
Order By: Relevance
“…Unlike umbilical cord blood and autologous grafts that are processed and volume-reduced before cryopreservation and storage, grafts from adult donors are typically collected as close to the date of infusion as possible and administered fresh to avoid losses in cell yield and/or loss of cell function that could affect immune reconstitution and transplant outcomes such as engraftment. 3,4 Moreover, infusing cryoprotectants such as dimethyl sulfoxide can be associated with infusion-related toxicity and/or may require washing of the product, which may further impact cell dose of the product. Importantly, the infusion of fresh cells may reduce costs associated with processing, cryopreservation, and storage.…”
mentioning
confidence: 99%
“…Unlike umbilical cord blood and autologous grafts that are processed and volume-reduced before cryopreservation and storage, grafts from adult donors are typically collected as close to the date of infusion as possible and administered fresh to avoid losses in cell yield and/or loss of cell function that could affect immune reconstitution and transplant outcomes such as engraftment. 3,4 Moreover, infusing cryoprotectants such as dimethyl sulfoxide can be associated with infusion-related toxicity and/or may require washing of the product, which may further impact cell dose of the product. Importantly, the infusion of fresh cells may reduce costs associated with processing, cryopreservation, and storage.…”
mentioning
confidence: 99%
“…11,[14][15][16][17][18] The Ben laboratory has been designing and synthesizing small molecule IRIs and has demonstrated their advantages in many in vitro cellular systems. 4,[19][20][21][22][23] The structure of aldonamide-derived IRI is shown in Fig. 1.…”
Section: Resultsmentioning
confidence: 99%
“…The CD34 counts were performed as previously described. Colony-forming units were enumerated using an automated counter (Stem Cell Technologies, Vancouver, Canada) using standard culture methods that estimate the longer-term engraftment potential of cord blood units, as described previously [16]. The number of CD34-positive per 10 3 TNC and the number of CFUs per 10 4 TNC were determined to assess enrichment for hematopoietic stem and progenitor cells.…”
Section: Discussionmentioning
confidence: 99%